title: Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.
authors: National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Faculty of Medicine, University of Oslo, Norway knusme@ous-hf.no.
authors: Knut B
authors: KB
authors: Smeland
authors: National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway.
authors: Cecilie E
authors: CE
authors: Kiserud
authors: Department of Oncology, Oslo University Hospital, Norway.
authors: Grete F
authors: GF
authors: Lauritzsen
authors: Department of Oncology, St. Olavs Hospital, Trondheim, Norway Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
authors: Unn-Merete
authors: UM
authors: Fagerli
authors: Oslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Norway.
authors: Ragnhild S
authors: RS
authors: Falk
authors: Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
authors: Øystein
authors: Ø
authors: Fluge
authors: Department of Oncology, Oslo University Hospital, Norway.
authors: Alexander
authors: A
authors: Fosså
authors: Department of Oncology, Oslo University Hospital, Norway.
authors: Arne
authors: A
authors: Kolstad
authors: National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway Department of Behavioural Sciences in Medicine, Faculty of Medicine, University of Oslo, Norway.
authors: Jon H
authors: JH
authors: Loge
authors: Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
authors: Martin
authors: M
authors: Maisenhölder
authors: Faculty of Medicine, University of Oslo, Norway Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Norway.
authors: Stein
authors: S
authors: Kvaløy
authors: Department of Oncology, Oslo University Hospital, Norway.
authors: Harald
authors: H
authors: Holte
mesh_terms: D015331:Cohort Studies; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000401:mortality* / Q000639:trends; D006689:Hodgkin Disease / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000401:mortality*; D009664:Norway / Q000453:epidemiology; D012008:Recurrence; D012042:Registries; D015996:Survival Rate / Q000639:trends; D014182:Transplantation, Autologous
keywords: autologous stem cell transplantation; high-dose therapy; mortality; non-Hodgkin lymphoma; survival